Evidence map›Paper›PMID 35867649›Full record

ArticlePloS one2022

Kinetics of Bovine leukemia virus aspartic protease reveals its dimerization and conformational change.

Martín Fló, Federico Carrión, Natalia Olivero-Deibe, Sergio Bianchi, Madelón Portela, Florencia Rammauro, Beatriz Alvarez, Otto Pritsch

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Martín FlóLaboratorio de Inmunovirología, Institut Pasteur de Montevideo, Montevideo, Uruguay.ORCID 0000-0002-6514-4270
Federico CarriónLaboratorio de Inmunovirología, Institut Pasteur de Montevideo, Montevideo, Uruguay.ORCID 0000-0003-4092-2168
Natalia Olivero-DeibeLaboratorio de Inmunovirología, Institut Pasteur de Montevideo, Montevideo, Uruguay.
Sergio BianchiLaboratorio de Inmunovirología, Institut Pasteur de Montevideo, Montevideo, Uruguay.
Madelón PortelaUnidad de Bioquímica y Proteómica Analíticas, Institut Pasteur de Montevideo, Facultad de Ciencias, Montevideo, Uruguay.
Florencia RammauroLaboratorio de Inmunovirología, Institut Pasteur de Montevideo, Montevideo, Uruguay.
Beatriz AlvarezLaboratorio de Enzimología, Instituto de Química Biológica, Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay.
Otto PritschLaboratorio de Inmunovirología, Institut Pasteur de Montevideo, Montevideo, Uruguay.
Universidad de la República de Uruguay · UYInstitut Pasteur de Montevideo · UY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The retropepsin (PR) of the Bovine leukemia virus (BLV) plays, as in other retroviruses, a crucial role in the transition from the non-infective viral particle to the infective virion by processing the polyprotein Gag. PR is expressed as an immature precursor associated with Gag, after an occasional -1 ribosomal frameshifting event. Self-hydrolysis of PR at specific N- and C-terminal sites releases the monomer that dimerizes giving rise to the active protease. We designed a strategy to express BLV PR in E. coli as a fusion protein with maltose binding protein, with a six-histidine tag at its N-terminal end, and bearing a tobacco etch virus protease hydrolysis site. This allowed us to obtain soluble and mature recombinant PR in relatively good yields, with exactly the same amino acid composition as the native protein. As PR presents relative promiscuity for the hydrolysis sites we designed four fluorogenic peptide substrates based on Förster resonance energy transfer (FRET) in order to characterize the activity of the recombinant enzyme. These substrates opened the way to perform kinetic studies, allowing us to characterize the dimer-monomer equilibrium. Furthermore, we obtained kinetic evidence for the existence of a conformational change that enables the interaction with the substrate. These results constitute a starting point for the elucidation of the kinetic properties of BLV-PR, and may be relevant not only to improve the chemical warfare against this virus but also to better understand other viral PRs.

Indexed as

Aspartic Acid ProteasesLeukemia Virus, BovineDimerizationEscherichia coliHIV ProteaseKineticsPeptide HydrolasesAspartic Acid ProteasesHIV ProteasePeptide Hydrolases

Identifiers

PMID35867649
PMCPMC9307154
OpenAlexW4286697325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.